Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics 2020

Abraham Lee's Biography

Abraham Lee, Professor, University of California Irvine

Abraham (Abe) P. Lee is Professor of Biomedical Engineering (BME) and Mechanical and Aerospace Engineering (MAE) at the University of California, Irvine. He is Director of the NSF I/UCRC “Center for Advanced Design & Manufacturing of Integrated Microfluidics” (CADMIM). Currently Dr. Lee serves as Editor-in-Chief for the Lab on a Chip journal. Prior to UCI, he was a program manager in the Microsystems Technology Office at DARPA (1999-2001) and a group leader with Lawrence Livermore National Lab. Over the years, Dr. Lee has pioneered research in applying microfluidics to biomedical applications, and currently focuses on integrated microfluidic systems for precision medicine. His research has contributed to the founding of several start-up companies. He owns 45 issued US patents and is author of over 100 journals articles. Professor Lee was awarded the 2009 Pioneers of Miniaturization Prize and is an elected fellow of the NAI, AIMBE, RSC, ASME, and BMES.

Abraham Lee Image

Microfluidic Cell Engineering for Precision Therapy

Tuesday, 29 September 2020 at 15:00

Add to Calendar ▼2020-09-29 15:00:002020-09-29 16:00:00Europe/LondonMicrofluidic Cell Engineering for Precision TherapyLab-on-a-Chip and Microfluidics 2020 in Virtual ConferenceVirtual

Precision medicine is the paradigm to develop treatments for patients based on molecular-targets that are effective in vivo when administered.  That is, one must not only be able to identify molecular and cellular targets that are the source of disease but also understand how these targets behave in the body based on physiological principles.  Recent developments in microfluidics have contributed to burgeoning precision medicine fields such as liquid biopsy, immunotherapy, single cell analysis, genotyping and gene sequencing, and microphysiological systems.  A specific focus of my talk would be on microfluidic devices for engineering cells for developing targeted cell therapies and immunotherapies. These microfluidic technologies have the potential to close the loop from detection to diagnosis, to therapy.

Add to Calendar ▼2020-09-28 00:00:002020-09-30 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics 2020Lab-on-a-Chip and Microfluidics 2020 in Virtual ConferenceVirtual